Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Oct 15.

Published in final edited form as: Cancer. 2019 Jul 10;125(20):3666–3677. doi: 10.1002/cncr.32370

Figure 2. — (A) Neurocognitive outcomes of survivors and siblings within each racial/ethnic group as standardized T-scores, sibling mean=50 SD=10. (B) Emotional (BSI-18) outcomes of survivors and siblings within each racial/ethnic group as standardized T-scores, general population mean=50 SD=10. For both outcomes, higher scores indicate worse function; P-values compare each survivor group to same race/ethnicity sibling group adjusted for sex, age at follow-up, year at diagnosis, methotrexate exposure (intravenous and intrathecal), corticosteroid exposure and any CTCAE grade 3-4 chronic medical condition. NHW=non-Hispanic white, NHB=non-Hispanic black, RT=cranial radiation therapy

Figure 2. — (A) Neurocognitive outcomes of survivors and siblings within each racial/ethnic group as standardized T-scores, sibling mean=50 SD=10. (B) Emotional (BSI-18) outcomes of survivors and siblings within each racial/ethnic group as standardized T-scores, general population mean=50 SD=10. For both outcomes, higher scores indicate worse function; P-values compare each survivor group to same race/ethnicity sibling group adjusted for sex, age at follow-up, year at diagnosis, methotrexate exposure (intravenous and intrathecal), corticosteroid exposure and any CTCAE grade 3-4 chronic medical condition. NHW=non-Hispanic white, NHB=non-Hispanic black, RT=cranial radiation therapy